Tesamorelin – Growth Hormone-Releasing Peptide for Metabolic and Lipodystrophy Research
Tesamorelin is a synthetic peptide analog of Growth Hormone-Releasing Hormone (GHRH), developed to stimulate endogenous growth hormone production. It has been extensively studied for its role in reducing visceral adipose tissue, improving lipid profiles, and supporting metabolic function, particularly in research models related to HIV-associated lipodystrophy and age-related fat accumulation.

At NanoPeptideResearch, we provide Tesamorelin in ultra-pure, research-grade form, optimized for laboratory use only. This compound is not intended for human use, medical treatment, or therapeutic application.

Why Researchers Choose NanoPeptideResearch:

• Pharmaceutical-grade peptides for accurate, reproducible studies

• Trusted source for metabolic and endocrine research compounds

• Fast, secure shipping for academic and institutional labs worldwide

Unlock the potential of growth hormone modulation with Tesamorelin—available now at NanoPeptideResearch, your reliable partner in advanced peptide science.